U

Management Team

Johannes Doll

Johannes Doll

  • President and CEO
  • Born: 1981
  • Nationality: German
  • Position: President and CEO since October 2021.
  • Education and professional experience: Johannes holds an MBA, from the University of Texas, and Dipl. Kaufmann, WHU Otto Beisheim School of Management, Germany. From 2013-2021, Johannes was part of the Executive Management team at Orexo AB, most recently as Executive Vice President and Chief Commercial Officer. Prior to joining Orexo, Johannes worked at McKinsey & Company from 2004 to 2013, advising international clients in the pharmaceutical and medical devices industry and the private equity sector.
  • Shareholding in Sedana Medical: 117,630 shares, 495,000 warrants and 226,762 rights to receive shares.
Stefan Krisch

Stefan Krisch

  • Supply Chain and Manufacturing Director
  • Born: 1974
  • Nationality: Swedish
  • Position: Supply Chain and Manufacturing Director since March 2021.
  • Education and professional experience: Stefan holds an M.Sc. in Mechanical Engineering from the Royal Institute of Technology (KTH) Stockholm, Sweden, and TUD Darmstadt, Germany. In addition, he studied business administration and management at Stockholm Business School, Stockholm University. Stefan has around 20 years of experience in leading positions in various industries, principally in manufacturing, logistics, and business development. Former CEO of Svensk Dos AB, CEO of Dipylon Medical AB, and Production Manager at AB Gustavsberg. Founder of Eker Bicycles AB and Eker Production Ltd., Uganda.
  • Other current engagement: Chairman of the Board Eker Bicycles AB and Eker Production Ltd., Uganda. Owner K-Consulting (sole proprietor).
  • Shareholding in Sedana Medical: 32,600 shares, 49,200 warrants and 70,863 rights to receive shares.
Stefan Krisch

Peter Sackey

  • Chief Medical Officer
  • Born: 1971
  • Nationality: Swedish
  • Position: Chief Medical Officer of Sedana Medical since January 2018.
  • Education and professional experience: Peter received his doctor´s degree from Karolinska Institutet, Stockholm, in 1997. Before joining Sedana Medical, he worked for twenty years at the Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, and is Board-certified in Anesthesiology (DESA) and Intensive Care (EDIC). He completed his Ph.D. thesis entitled “Isoflurane sedation in Intensive Care Unit patients” at Karolinska Institutet in 2006. He is an Associate professor at Karolinska Institutet, has supervised several Ph.D. students in ICU sedation, pain monitoring, and long-term outcomes research, and remains active in ICU-related research. Previous positions: Senior Consultant, Head of Neurocritical Care, Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital.
  • Other current engagement: Associate professor, Department of Physiology and Pharmacology, Karolinska Institutet.
  • Shareholding in Sedana Medical: 229,468 shares, 69,073 warrants and 70,863 rights to receive shares.
Stefan Krisch

Johan Spetz

  • Chief Financial Officer
  • Born: 1984
  • Nationality: Swedish
  • Position: Chief Financial Officer since April 2022.
  • Education and professional experience: Johan holds an M.Sc. in Economics and Business Administration from the Stockholm School of Economics (Handelshögskolan). Over the period 2013-2021, Johan worked at the investment bank Pareto Securities, of which 2015-2021 as partner and Head of Equity Research in Stockholm. Prior to joining Pareto Securities, Johan worked as a financial analyst at Goldman Sachs in London and New York, 2009 – 2013.
  • Shareholding in Sedana Medical: 115,073 shares, 69,073 warrants and 70,863 rights to receive shares.
Stefan Krisch

Karolina Vilval

  • General Counsel
  • Born: 1979
  • Nationality: Swedish
  • Position: General Counsel since August 2022.
  • Education and professional experience: Karolina has a law degree from Stockholm University. Karolina has been active as a legal counsel in the pharmaceutical industry for more than 15 years. Prior to joining Sedana Medical, Karolina worked at Oncopeptides as General Counsel. Previously, Karolina has worked at Gilead Sciences, Biovitrum, and Swedish Orphan Biovitrum (Sobi) in various positions in Legal Affairs.
  • Shareholding in Sedana Medical: No shares. 70,863 rights to receive shares.
Stefan Krisch

Jessica Westfal

  • Vice President Regulatory Affairs and QA
  • Born: 1974
  • Nationality: Swedish
  • Position: Vice President Regulatory Affairs and QA since May 2020.
  • Education and professional experience: Jessica holds an M.Sc. in Analytical Chemistry at Umeå University, Sweden. She is a former employee at Unimedic AB (2006-2020) as Head of Quality and Product Development, and before that at AstraZeneca (1998-2006).
  • Shareholding in Sedana Medical: No shares. 18,260 warrants and 70,863 rights to receive shares. Related parties 5,692 shares.
Stefan Krisch

Uwe Veismann

  • General Manager Germany
  • Born: 1981
  • Nationality: German
  • Position: General Manager Germany since July 2023, formerly Country Manager Germany.
  • Education and professional experience: Uwe holds a Healthcare and Nursing Degree from University of Münster since 2003 with a State Exam in Intensive care and Anesthesia from 2008 with six years of clinical experiences in different medical departments. In addition, Uwe holds a Bachelor Professional of Pharmaceutical Consultancy (CCI) from October 2021. He started his career in Sedana Medical as Area Sales Manager in October 2009 and was promoted to Country Manager Germany in 2016, as of July 2023 he holds the position of General Manager Germany.
  • Shareholding in Sedana Medical: No shares. 70,863 rights to receive shares.
Stefan Krisch

Sinéad Renouf-Wood

  • Vice President Marketing
  • Born: 1986
  • Nationality: British
  • Position: Vice President Marketing since April 2025.
  • Education and professional experience: Sinéad holds an MSc in Marketing Management from the University of Central Lancashire and brings over 15 years of commercial and strategic marketing experience in the Medtech sector, with a focus on Anaesthesia and Respiratory Care. Since 2019 , she has held senior roles at Aerogen, most lately as Global Strategic Marketing Manager and Interim Marketing Director. Her prior roles at Venner Medical, Teleflex and LMA included responsibility for global product management and new market development. 
  • Shareholding in Sedana Medical: No shares.
Stefan Krisch

David Bergström

  • Vice President Operations, Supply and R&D
  • Born: 1969
  • Nationality: Swedish
  • Position: Vice President Operations, Supply and R&D since June 2025.
  • Education and professional experience: David holds a Ph.D in Physics and a M.Sc. in Engineering Physics, from the Royal Institute of Technology, Stockholm. From 2018-2025, David was leading the Becton Dickinson (BD) Infusion System R&D team in Limerick, Ireland. Prior to joining BD, David worked at Philips Healthcare as a Business Integration Leader at Philips Digital Pathology in the UK and as a Senior Systems manager at Philips Digital Mammography in India. Earlier in his career, David was in various leadership roles in R&D and Operations at the Digital Mammography Solutions business unit at Sectra (acquired by Philips Healthcare in 2011), Sweden.
  • Shareholding in Sedana Medical: 5,000 shares.
Stefan Krisch

Karolin Sjösten

  • Vice President Human Resources
  • Born: 1979
  • Nationality: Swedish
  • Position: Vice President Human Resources since August 2025.
  • Education and professional experience: Karolin holds a degree in Human Resource Management from Stockholm University and brings over 15 years of HR leadership experience across multiple industries, with the last five years dedicated to the Life Science sector. Prior to joining Sedana Medical, she was HR Director at A3P Biomedical and has also held HR roles at Orexo AB and within the aviation industry. In addition to her corporate positions, Karolin has served as an Organizational Consultant with a strong track record in leadership development, change management, and organizational effectiveness.
  • Shareholding in Sedana Medical: 0